TransCode Therapeutics up as brain cancer drug shows promise in animal study
Brief: Transcode Therapeutics Reports Positive Preclinical Results With TTX-MC138
Brief: Transcode Therapeutics Offers Up To 1.5 Mln Shares With Series A Warrants
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill
TransCode Therapeutics slips on reverse stock split
Brief: Transcode Therapeutics Announces 1-For-20 Reverse Stock Split
Brief: Transcode Therapeutics Inc Says On May 16, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: TransCode Therapeutics Announces IRB Approval For FDA Cleared First-In-Human Clinical Trial
Brief: Transcode Therapeutics Receives Equity Investment From White Lion Capital
Brief: Transcode Therapeutics Receives Notice Of Award From National Institutes Of Health (Nih)
Brief: Transcode Therapeutics Announces Orphan Drug Designation Status For Ttx-Mc138 For Treatment Of Pancreatic Cancer
Brief: Transcode Therapeutics Inc Files Prospectus For Offering Of 12 Million Shares Of Our Common Stock - SEC Filing
Brief: Transcode Therapeutics Inc - Estimate Cash Of Approximately $5.0 Million As Of December 31, 2022
Brief: Transcode Therapeutics Reports Positive Preclinical Results With Its Immunotherapy Candidate In Melanoma
U.S. STOCKS ON THE MOVE-Conagra Brands, Apple, Taylor Devices
U.S. STOCKS ON THE MOVE-Bitfarms, Hoth Therapeutics, Boralex
U.S. STOCKS ON THE MOVE-Hyzon Motors, TG Therapeutics, Newmont